NCT02088164

Brief Summary

To determine the long-term survival outcome of subjects who had various PSA levels at screening

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27,741

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2012

Completed
1.8 years until next milestone

First Posted

Study publicly available on registry

March 14, 2014

Completed
Last Updated

March 14, 2014

Status Verified

March 1, 2014

Enrollment Period

2 months

First QC Date

May 16, 2012

Last Update Submit

March 13, 2014

Conditions

Prostate Cancer

Keywords

PSA,asian men,survival

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of prostate cancer

    20 years (average)

Secondary Outcomes (2)

  • Cancer-specific death

    20 years (average)

  • Overall survival

    20 years (average)

Study Arms (1)

Healthy men

Healthy men who received PSA screening

Eligibility Criteria

Age41 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Taiwanese healthy men who are older than 40 years

You may qualify if:

  • Health men who received PSA screening at NTUH and CGMH

You may not qualify if:

  • Prior history of prostate cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • Yeong-Shiau Pu, PhD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2012

First Posted

March 14, 2014

Study Start

February 1, 2012

Primary Completion

April 1, 2012

Last Updated

March 14, 2014

Record last verified: 2014-03

Locations

TW(1)